ROBOT-ASSISTED PELVIC LYMPH NODE DISSECTION USING ICG TESTING IN PATIENTS WITH PROSTATE CANCER

The objective is to investigate the possibility of using fluorescent testing in robot-assisted radical prostatectomy using indocyanine green (ICG testing) during pelvic lymph node dissection (PLND) in patients with localized prostate cancer.

Materials and methods. Fifteen minutes prior to robot-assisted PLND, intraprostatic transperineal administration of 0.4 ml of indocyanine green (ICG) per lobe under transrectal ultrasound control was performed. Fluorescence map was used. After activation of the FireFly mode, fluorescence of the lymph nodes was evaluated. If a sentinel lymph node was present, lymph node dissection was performed using the FireFly mode. If fluorescence was diffuse, PLND using this option wasn’t performed.

Results. In total, 35 patients with localized prostate cancer underwent surgery. Mean age was 62.0 ± 6.5 years (41–68 years), mean prostatespecific antigen level prior to surgery was 15.6 ± 11.3 ng/ml (1.5–27.0 ng/ml).  Postoperative examination revealed micrometastases in the lymph nodes in 7 (20 %) cases. Sentinel lymph nodes were detected in 29 patients. Intraoperative examination revealed sentinel lymph nodes metastases in 6 (17 %) cases, in other cases (83 %) metastases were absent. Morphological examination showed that in 5 (83 %) of 6 patients with lesions in the sentinel lymph node, micrometastases in other lymph nodes were present. In patients without lesions in the sentinel lymph node, no micrometastases in other lymph nodes were observed. PLND complications included lymphocele in 3 (8 %) patients, prolonged drain indwelling time in 5 (14 %) patients.

Conclusion. Initial experience of our clinic shows reproducibility and low complications profile of fluorescence monitoring in the near-infrared region using ICG testing during robot-assisted PNLD. In conditions of continuous increase in the number of performed robot-assisted radical prostatectomies, ICG testing is a promising minimally invasive method for evaluation of regional metastases allowing to detect the sentinel lymph node. This approach allows to decrease the number of complications associated with PLND.

1. Wilt T.J., Brawer M.K., Jones K.M. et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012;367(3):203–13. DOI: 10.1056/NEJMoa1113162. PMID: 22808955.

2. Bill-Axelson A., Holmberg L., Garmo H. et al. Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med 2014;370(10):932–42. DOI: 10.1056/NEJMoa1311593. PMID: 24597866.

3. Yaxley J.W., Coughlin G.D., Chambers S.K. et al. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study. Lancet 2016;388(10049):1057–66. DOI: 10.1016/S0140-6736(16)30592-X. PMID: 27474375.

4. Allan C., Ilic D. Laparoscopic versus robotic-assisted radical prostatectomy for the treatment of localised prostate cancer: a systematic review. Urol Int 2016;96(4):373–8. DOI: 10.1159/000435861. PMID: 26201500.

5. Fossati N., Willemse P.M., Van den Broeck T. et al. The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review. Eur Urol 2017;72(1):84–109. DOI: 10.1016/j.eururo.2016.12.003. PMID: 28126351.

6. Harisinghani M.G., Barentsz J., Hahn P.F. et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003;348(25):2491– 9. DOI: 10.1056/NEJMoa022749. PMID: 12815134.

7. Abdollah F., Gandaglia G., Suardi N. et al. More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer. Eur Urol 2015;67(2):212–9. DOI: 10.1016/j.eururo.2014.05.011. PMID: 24882672.

8. Hövels A.M., Heesakkers R.A., Adang E.M. et al. The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a metaanalysis. Clin Radiol 2008;63(4):387–95. DOI: 10.1016/j.crad.2007.05.022. PMID: 18325358.

9. Daneshmand S., Quek M.L., Stein J.P. et al. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol 2004;172(6 Pt 1):2252–5. PMID: 15538242.

10. Sanda G., Chen R., Crispino T. et al. Clinically localized prostate cancer: AUA/ASTRO/SUO Guideline, 2017.

11. Mottet N., Bellmunt J., Briers E. et al. EAU–ESTRO–SIOG Prostate Cancer Guidelines, 2017.

12. Tobis S., Knopf J.K., Silvers C. et al. Robot-assisted and laparoscopic partial nephrectomy with near infrared fluorescence imaging. J Endourol 2012;26(7):797–802. DOI: 10.1089/end.2011.0604. PMID: 22250958.

13. Manny T.B., Patel M., Hemal A.K. Fluorescence-enhanced robotic radical prostatectomy using real-time lymphangiography and tissue marking with percutaneous injection of unconjugated indocyanine green: the initial clinical experience in 50 patients. Eur Urol 2014;65(6):1162–8. DOI: 10.1016/j.eururo.2013.11.017. PMID: 24289911.

14. Steineck G., Helgesen F., Adolfsson J. et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 2002;347(11):790–6. DOI: 10.1056/NEJ-Moa021483. PMID: 12226149.

15. van As N.J., Norman A.R., Thomas K. et al. Predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance. Eur Urol 2008;54(6):1297–305. DOI: 10.1016/j.eururo.2008.02.039. PMID: 18342430.

16. Carter H.B., Kettermann A., Warlick C. et al. Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience. J Urol 2007;178(6):2359–64. DOI: 10.1016/j.juro.2007.08.039. PMID: 17936806.

17. Seiler R., Studer U.E., Tschan K. et al. Removal of limited nodal disease in patients undergoing radical prostatectomy: long-term results confirm a chance for cure. J Urol 2014;191(5):1280–5. DOI: 10.1016/j.juro.2013.11.029. PMID: 24262495.

18. Briganti A., Chun F.K., Salonia A. et al. Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy. Eur Urol 2006;49(6):1019–26. DOI: 10.1016/j.eururo.2006.01.043. PMID: 16530933.

19. Ramírez-Backhaus M., Mira Moreno A., Gómez Ferrer A. et al. Indocyanine green guided pelvic lymph node dissection: an efficient technique to classify the lymph node status of patients with prostate cancer who underwent radical prostatectomy. J Urol 2016;196(5):1429–35. DOI: 10.1016/j.juro.2016.05.087. PMID: 27235788.

20. Yee D.S., Katz D.J., Godoy G. et al. Extended pelvic lymph node dissection in robotic-assisted radical prostatectomy: surgical technique and initial experience. Urology. 2010 May;75(5):1199–204. DOI: 10.1016/j.urology.2009.06.103. PMID: 20163838.

21. Winter A., Vogt C., Weckermann D., Wawroschek F. Complications of pelvic lymphadenectomy in clinically localised prostate cancer: different techniques in comparison and dependency on the number of removed lymph nodes. Aktuelle Urol 2011;42(3):179–83. DOI: 10.1055/s-0031-1271389.

22. van der Poel H.G., Grivas N. Towards an individualized approach for predicting postprostatectomy urinary incontinence: the role of nerve preservation and urethral stump length. BJU Int 2018;122(3):354–5. DOI: 10.1111/bju.14205. PMID: 30187656.

23. van der Poel H.G., Buckle T., Brouwer O.R. et al. Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer. Eur Urol 2011;60(4):826–33. DOI: 10.1016/j.eururo.2011.03.024. PMID: 21458154.

24. Nguyen D.P., Huber P.M., Metzger T.A. et al. A specific mapping study using fluorescence sentinel lymph node detection in patients with intermediate- and high-risk prostate cancer undergoing extended pelvic lymph node dissection. Eur Urol 2016;70(5):734–7. DOI: 10.1016/j.eururo.2016.01.034. PMID: 26856960.

25. Chennamsetty A., Zhumkhawala A., Tobis S.B. et al. Lymph node fluorescence during robot-assisted radical prostatectomy with indocyanine green: prospective dosing analysis. Clin Genitourin Cancer 2017;15(4):e529–34. DOI: 10.1016/j.clgc.2016.10.014. PMID: 27939590.

26. van den Berg N.S., Buckle T., KleinJan G.H. et al. Multispectral fluorescence imaging during robot-assisted laparoscopic sentinel node biopsy: a first step towards a fluorescence-based anatomic roadmap. Eur Urol 2017;72(1):110–7. DOI: 10.1016/j.eururo.2016.06.012. PMID: 27345689.